Focus Partners Wealth’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Focus Partners Wealth's IDXX Position: Q3 2026 in Review
Focus Partners Wealth reduced its Idexx Laboratories (IDXX) stake by 3.9% in Q3 2026, selling an estimated $1.33M and leaving 59,480 shares worth $31.1M. The position accounts for 0.03% of the portfolio, ranked #405.
Focus Partners Wealth first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $41.4M in Q4 2025. 1,276 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Focus Partners Wealth held 59,480 shares of Idexx Laboratories worth $31.1M as of Q3 2026.
- Focus Partners Wealth sold 2,424 Idexx Laboratories shares in Q3 2026, an estimated $1.33M.
- Idexx Laboratories made up 0.03% of Focus Partners Wealth's portfolio in Q3 2026, its #405 holding.
- Focus Partners Wealth first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
- Focus Partners Wealth's Idexx Laboratories position peaked at $41.4M in Q4 2025.
- 1,276 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Focus Partners Wealth's 13F filing for Q3 2026, filed 12 Nov 2026.